GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Asian American Medical Group Ltd (ASX:AJJ) » Definitions » Debt-to-EBITDA

Asian American Medical Group (ASX:AJJ) Debt-to-EBITDA : 1.73 (As of Feb. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Asian American Medical Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Asian American Medical Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was A$0.70 Mil. Asian American Medical Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was A$0.00 Mil. Asian American Medical Group's annualized EBITDA for the quarter that ended in Feb. 2023 was A$0.41 Mil. Asian American Medical Group's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2023 was 1.73.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Asian American Medical Group's Debt-to-EBITDA or its related term are showing as below:

ASX:AJJ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.14   Med: -0.29   Max: 9.76
Current: 9.76

During the past 13 years, the highest Debt-to-EBITDA Ratio of Asian American Medical Group was 9.76. The lowest was -1.14. And the median was -0.29.

ASX:AJJ's Debt-to-EBITDA is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.57 vs ASX:AJJ: 9.76

Asian American Medical Group Debt-to-EBITDA Historical Data

The historical data trend for Asian American Medical Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asian American Medical Group Debt-to-EBITDA Chart

Asian American Medical Group Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -1.13 -0.29 -1.14

Asian American Medical Group Semi-Annual Data
Aug13 Feb14 Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.66 -0.20 -1.38 -2.93 1.73

Competitive Comparison of Asian American Medical Group's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Asian American Medical Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asian American Medical Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Asian American Medical Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Asian American Medical Group's Debt-to-EBITDA falls into.



Asian American Medical Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Asian American Medical Group's Debt-to-EBITDA for the fiscal year that ended in Aug. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.768 + 0) / -0.674
=-1.14

Asian American Medical Group's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.703 + 0) / 0.406
=1.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Feb. 2023) EBITDA data.


Asian American Medical Group  (ASX:AJJ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Asian American Medical Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Asian American Medical Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Asian American Medical Group (ASX:AJJ) Business Description

Traded in Other Exchanges
N/A
Address
6A Napier Road, Gleneagles Hospital Annexe Block Number 02-36A/36B/37, Singapore, SGP, 258500
Asian American Medical Group Ltd engages in the provision of specialized medical services. It operates through the following segments: Liver; Healthcare Management and Consultancy; Multi-Specialty; and Healthcare Real Estate. The Liver segment is engaged in the provision of medical consultation and services in hepatology and related fields. The Multi-specialty segment includes the provision of multi-specialty medical consultation and services in the medical pilot zone in Boao, Hainan cater to the healthcare needs of China. It provides healthcare management and consultancy services. It is also into the development of real estate projects. The firm generates the majority of its revenue from the Liver segment. Geographically it generates the vast majority of its revenue from Singapore.

Asian American Medical Group (ASX:AJJ) Headlines

No Headlines